Table 2.
Comparison of the patients with and without FOG
Without FOG | With FOG | ||||
---|---|---|---|---|---|
Mean ± SD | Range | Mean ± SD | Range | z; p | |
Age (years) | 64.58±11.47 | 27–85 | 67.50±9.31 | 47–84 | 1.330; 0.183 |
Duration of disease (years) | 6.83±7.12 | 1–37 | 7.86±6.11 | 1–35 | 1.750; 0.080 |
UPDRS motor score | 14.33±7.72 | 1–30 | 22.34±7.71 | 6–41 | 4.767; <0.001 |
HYS | 1.865±0.76 | 1–3 | 2.586±0.81 | 1–4 | 4.257; <0.001 |
Levodopa equivalent dose (mg) | 579.27±311.59 | 100–1600 | 777.82±597.27 | 0–2550 | 1.454; 0.146 |
FOG Questionnaire score | 2.77±3.82 | 0–18 | 15.10±6.06 | 1–24 | 7.973; <0.001 |
VAS score | 3.79±3.85 | 0–10 | 4.33±3.70 | 0–10 | 0.716; 0.474 |
FOG, freezing of gait; SD, standart deviation; UPDRS, unified Parkinson’s disease rating scale; HYS, Hoehn and Yahr scale.